L. Mary Smith Spring Works Therapeutics, Inc. (SWTX) insider trading activity

L. Mary Smith is Chief Development Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 233,363 shares of SWTX, which is worth approximately $8.59 Million. The most recent transaction as insider was on Jan 08, 2024, when has been sold 3,535 shares (Common Stock) at a price of $41.53 per share, resulting in proceeds of $146,808. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 233K

0% 3M change

7.08% 12M change

Total Value Held $8.59 Million

L. Mary Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2024	SELL Payment of exercise price or tax liability	$146,808 $41.53 p/Share	3,535 Reduced 1.49%	233,363 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$83,398 $37.96 p/Share	2,197 Reduced 0.92%	236,898 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	21,156 Added 8.13%	239,095 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	5,720 Added 2.56%	217,939 Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$28,205 $26.41 p/Share	1,068 Reduced 0.5%	212,219 Common Stock
Jan 06 2023	SELL Payment of exercise price or tax liability	$67,479 $27.52 p/Share	2,452 Reduced 1.14%	213,287 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	22,663 Added 9.51%	215,739 Common Stock
Jul 18 2022	SELL Payment of exercise price or tax liability	$44,157 $28.47 p/Share	1,551 Reduced 0.8%	193,076 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	6,092 Added 3.04%	194,627 Common Stock
Jan 07 2022	SELL Payment of exercise price or tax liability	$99,338 $56.06 p/Share	1,772 Reduced 0.93%	187,944 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	22,205 Added 10.48%	189,716 Common Stock
Oct 13 2021	SELL Open market or private sale	$559,700 $55.97 p/Share	10,000 Reduced 5.63%	167,511 Common Stock
Oct 13 2021	BUY Exercise of conversion of derivative security	$23,000 $2.3 p/Share	10,000 Added 5.33%	177,511 Common Stock
Jul 13 2021	SELL Open market or private sale	$808,800 $80.88 p/Share	10,000 Reduced 5.63%	167,511 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	$23,000 $2.3 p/Share	10,000 Added 5.33%	177,511 Common Stock
Apr 13 2021	SELL Open market or private sale	$680,700 $68.07 p/Share	10,000 Reduced 5.63%	167,511 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$23,000 $2.3 p/Share	10,000 Added 5.33%	177,511 Common Stock
Jan 20 2021	SELL Open market or private sale	$787,000 $78.7 p/Share	10,000 Reduced 5.63%	167,511 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$19,800 $1.98 p/Share	10,000 Added 5.33%	177,511 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	11,000 Added 6.16%	167,511 Common Stock

LMS

L. Mary Smith

Chief Development Officer

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX

Account